Matches in Wikidata for { <http://www.wikidata.org/entity/Q92697299> ?p ?o ?g. }
Showing items 1 to 43 of
43
with 100 items per page.
- Q92697299 description "articolo scientifico (pubblicato il 2020)" @default.
- Q92697299 description "artikull shkencor i botuar më 01 shkurt 2020" @default.
- Q92697299 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q92697299 description "scientific article published on 01 February 2020" @default.
- Q92697299 description "wetenschappelijk artikel" @default.
- Q92697299 description "наукова стаття, опублікована 1 лютого 2020" @default.
- Q92697299 name "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 name "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 type Item @default.
- Q92697299 label "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 label "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 prefLabel "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 prefLabel "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 P1433 Q92697299-9D973B1C-E8C2-429A-806F-6EEBF1D7E3D6 @default.
- Q92697299 P1476 Q92697299-376361A0-E719-4FCE-A4B8-636E79597EAE @default.
- Q92697299 P2093 Q92697299-2156FEEB-8D01-408F-BFA4-FBC2F8330782 @default.
- Q92697299 P2093 Q92697299-CEFEB213-113E-4EE6-BF9E-ABDC99255B38 @default.
- Q92697299 P2093 Q92697299-D4C8177B-0F49-46E2-99CC-289FEAA4AFB1 @default.
- Q92697299 P2860 Q92697299-F89AAEAD-06A9-4C3B-B5BB-3C88D606421F @default.
- Q92697299 P304 Q92697299-80C71A69-9A63-429C-9988-05CD5D39FB7F @default.
- Q92697299 P31 Q92697299-2531CA9A-0044-4A68-A8A0-BEC38E8A4747 @default.
- Q92697299 P356 Q92697299-342F7FBD-F64A-4D62-A0C9-EB03CAD4696A @default.
- Q92697299 P433 Q92697299-DD00A80A-2CD3-424C-8FE4-2150524BE605 @default.
- Q92697299 P478 Q92697299-FB9BC427-1DDA-4D61-AA50-31D9572925B4 @default.
- Q92697299 P577 Q92697299-69CC0DA7-25CE-44EA-BB6F-83B96BBC37E4 @default.
- Q92697299 P698 Q92697299-ADE63EF9-B7A3-4844-9F1C-579C14EBCC1F @default.
- Q92697299 P921 Q92697299-CABA02A5-B23B-4625-A257-C246C195D113 @default.
- Q92697299 P356 CMR.0000000000000635 @default.
- Q92697299 P698 31425478 @default.
- Q92697299 P1433 Q6811488 @default.
- Q92697299 P1476 "Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study" @default.
- Q92697299 P2093 "Bertil Damato" @default.
- Q92697299 P2093 "Heinrich Heimann" @default.
- Q92697299 P2093 "Rumana N Hussain" @default.
- Q92697299 P2860 Q36791086 @default.
- Q92697299 P304 "102-106" @default.
- Q92697299 P31 Q13442814 @default.
- Q92697299 P356 "10.1097/CMR.0000000000000635" @default.
- Q92697299 P433 "1" @default.
- Q92697299 P478 "30" @default.
- Q92697299 P577 "2020-02-01T00:00:00Z" @default.
- Q92697299 P698 "31425478" @default.
- Q92697299 P921 Q18554893 @default.